| 23716/34351 | US=67 / Imagem Avila RS. Quantitative imaging in CT lung cancer drug development and evaluation. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 39-51. ISBN 978-0-470-11880-1. CANCER DE PULMAO; IMAGENS QUANTITATIVAS; TOMOGRAFIA COMPUTADORIZADA; DESENVOLVIMENTO DE DROGAS |
| 23717/34351 | US=67 / Imagem Zhao B, Schwartz LH. Volumetric ct imaging for response assessment in lung cancer: a platform for translational research. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 53-66. ISBN 978-0-470-11880-1. CANCER DE PULMAO; TOMOGRAFIA COMPUTADORIZADA VOLUMETRICA; PESQUISA TRANSLACIONAL; APLICACOES INFORMATICAS |
| 23718/34351 | US=67 / Imagem Pearson J, Tarbox L, Paladini G, Wolodzko JG, Jacobs PM, Lee Z. Emerging radiological software standards and development technologies: impact on clinical translation and trials. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 67-93. ISBN 978-0-470-11880-1. PADROES RADIOLOGICOS EMERGENTES; SOFTWARE; TECNOLOGIAS DE DESENVOLVIMENTO; TRADUCAO; ENSAIOS CLINICOS |
| 23719/34351 | US=67 / Imagem Mazumdar M, Zhou XK. Statistical considerations underlying therapeutic response criteria for lung cancer: multislice ct scanners and cad algorithms for volumetric assessment. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 95-109. ISBN 978-0-470-11880-1. CANCER DE PULMAO; CONSIDERACOES ESTATISTICAS SUBJACENTES; CRITERIOS DE RESPOSTA TERAPEUTICAS; TOMOGRAFIA MULTISLICE SCANNERS; ALGORITMOS DE CAD; AVALIACAO VOLUMETRICA |
| 23720/34351 | US=67 / Imagem Baer TM, Clark CW, Karam L. Programs supporting quantitative imaging in biomedicine at the national institute of standards and technology. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 111-22. ISBN 978-0-470-11880-1. CANCER DE PULMAO; PROGRAMAS DE APOIO; IMAGENS QUANTITATIVAS; BIOMEDICINA; INSTITUTO NACIONAL DE PADROES E TECNOLOGIA |
| 23721/34351 | US=67 / Imagem Clarke L, Reeves AP, Yankelevitz DF. Evolving imaging resources: public access databases. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 123-30. ISBN 978-0-470-11880-1. EVOLUCAO DOS RECURSOS DE IMAGEM; BASES DE DADOS DE ACESSO PUBLICO |
| 23722/34351 | US=67 / Imagem Baer TM, Mulshine JL. Biomedical imaging archive network. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 131-40. ISBN 978-0-470-11880-1. IMAGEM BIOMEDICA; ARQUIVO DE REDE; BASES DE DADOS; BIOLOGIA MOLECULAR; IMAGEM QUANTITATIVA |
| 23723/34351 | US=67 / Imagem Mulshine JL, Avila RS, Hirsch FR, Yankelevitz DF. Developing CT image-processing tools to accelerate progress in lung cancer drug development. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 141-54. ISBN 978-0-470-11880-1. CANCER DE PULMAO; TOMOGRAFIA COMPUTADORIZADA; DESENVOLVIMENTO DE PROCESSAMENTO DE IMAGEM; FERRAMENTAS; DESENVOLVIMENTO DE DROGAS |
| 23724/34351 | US=69 / Câncer Wheler J, Kurzrock R. Perspectives: bench to bedside and back. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 1-19. ISBN 978-1-60327-423-4. TERAPIA DE CANCER DIRECIONADA; MEDICINA TRANSLACIONAL; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR |
| 23725/34351 | US=69 / Câncer Estey E. Targeted therapy in acute myelogenous leukemia. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 21-42. ISBN 978-1-60327-423-4. TERAPIA DE CANCER DIRECIONADA; TERAPIA-ALVO NA LEUCEMIA MIELOIDE AGUDA; LEUCEMIA MIELOIDE AGUDA; ATRA E ARSENICO TRIOXIDO OZOGAMICINA; FLT-3 INIBIDORES; INIBIDORES DA FARNESIL TRANSFERASE; EPIGENETICA AGENTES DE ACAO |
| 23726/34351 | US=69 / Câncer Craft BS, Moulder S. Targeted therapy in breast cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 43-59. ISBN 978-1-60327-423-4. TERAPIA-ALVO NO CANCRO DA MAMA; CANCER DE MAMA; TERAPIA BIOLOGICA; TERAPIA-ALVO; TERAPIA ADJUVANTE; DOENCA METASTATICA |
| 23727/34351 | US=69 / Câncer Tsimberidou AM, Keating MJ. Targeted therapy in chronic lymphocytic leukemia. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 61-86. ISBN 978-1-60327-423-4. TERAPIA-ALVO EM LEUCEMIA LINFOCITICA CRONICA; CLL; PROGNOSTICO; TERAPIA; ALVO; FASE I; FLUDARABINA; ALEMTUZUMAB; RITUXIMAB; LENALIDOMIDA; TERAPIA GENETICA |
| 23728/34351 | US=69 / Câncer Jabbour E, Cortes J, Kantarjian H. Targeted therapy in chronic myeloid leukemia. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 87-99. ISBN 978-1-60327-423-4. TERAPIA-ALVO NA LEUCEMIA MIELOIDE CRONICA; LEUCEMIA MIELOIDE CRONICA; INIBIDOR DA TIROSINA QUINASE; RESISTENCIA; BCR-ABL |
| 23729/34351 | US=69 / Câncer Kopetz S. Targeted therapy in colorectal cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 101-23. ISBN 978-1-60327-423-4. TERAPIA-ALVO; CANCER COLORRETAL; EGFR; VEGF; ANTICORPOS MONOCLONAIS |
| 23730/34351 | US=69 / Câncer Stewart DJ. Targeted therapy in non-small cell lung cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 125-56. ISBN 978-1-60327-423-4. TERAPIA-ALVO; NAO-PEQUENAS DE CANCER DE PULMAO DE CELULAS; EGFR; ERLOTINIB; GEFITINIB; VEGFR |
| 23731/34351 | US=69 / Câncer Wedgwood A, Younes A. Targeted therapy in lymphoma. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 157-82. ISBN 978-1-60327-423-4. TERAPIA-ALVO NO LINFOMA; ANTICORPO; LINFOMA; ANTIGENO; RECEPTOR; INIBIDOR; QUINASE |
| 23732/34351 | US=69 / Câncer Davies M, Patel S, Kim KB. Targeted therapy in melanoma. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 183-211. ISBN 978-1-60327-423-4. TERAPIA-ALVO EM PACIENTES COM MELANOMA; MELANOMA; TRANSDUCAO DE SINAL; QUINASE DO RECEPTOR; B-RAF; N-RAS; PTEN; MAP QUINASE; NFKB; ANTIOGENESIS; IMMUNOTARGETING |
| 23733/34351 | US=69 / Câncer Zhou Y, Alexanian R, Wang M. Targeted therapy in multiple myeloma. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 213-36. ISBN 978-1-60327-423-4. TERAPIA-ALVO; MIELOMA MULTIPLO; PATOGENESE MOLECULAR; MICROAMBIENTE |
| 23734/34351 | US=69 / Câncer Quintás-Cardama A, Kantarjian H, Garcia-Manero G, Cortes J. Targeted therapy in myelodysplastic syndrome. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 237-60. ISBN 978-1-60327-423-4. TERAPIA-ALVO; SINDROME MIELODISPLASICA; DECITABINA; A METILACAO DO DNA; 5-AZACITIDINA; LENALIDOMIDA |
| 23735/34351 | US=69 / Câncer Markman M. Targeted therapy in epithelial ovarian cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 261-9. ISBN 978-1-60327-423-4. TERAPIA-ALVO; CANCER EPITELIAL DE OVARIO; CANCRO DO OVARIO; CISPLATINA; CARBOPLATINA; AGENTES ANTI-ANGIOGENICOS; BEVACIZUMAB |